» Articles » PMID: 37543511

Adrenal Steroid Metabolites and Bone Status in Patients with Adrenal Incidentalomas and Hypercortisolism

Abstract

Background: Autonomous cortisol secretion (ACS), resulting from cortisol-producing adenomas (CPA), causes endogenous steroid-induced osteoporosis (SIOP). However, the risk of endogenous SIOP cannot be explained by cortisol excess alone, and how other steroid metabolites affect bone status is unclear.

Methods: ACS was diagnosed as serum cortisol ≥1.8 μg/dL after the 1-mg dexamethasone suppression test (DST-cortisol). Using liquid chromatography tandem mass spectrometry, 21 plasma steroid metabolites were measured in 73 patients with ACS and 85 patients with non-functioning adrenal tumors (NFAT). Expression of steroidogenic enzymes and relevant steroid metabolites were analyzed in some of CPA tissues.

Findings: Discriminant and principal component analyses distinguished steroid profiles between the ACS and NFAT groups in premenopausal women. Premenopausal women with ACS exhibited higher levels of a mineralocorticoid metabolite, 11-deoxycorticosterone (11-DOC), and lower levels of androgen metabolites, dehydroepiandrosterone-sulfate, and androsterone-glucuronide. In premenopausal women with ACS, DST-cortisol negatively correlated with trabecular bone score (TBS). Additionally, 11-DOC negatively correlated with lumbar spine-bone mineral density, whereas androsterone-glucuronide positively correlated with TBS. The CPA tissues showed increased 11-DOC levels with increased expression of CYP21A2, essential for 11-DOC synthesis. Adrenal non-tumor tissues were atrophied with reduced expression of CYB5A, required for androgen synthesis.

Interpretation: This study demonstrates that unbalanced production of adrenal steroid metabolites, derived from both adrenal tumor and non-tumor tissues, contributes to the pathogenesis of endogenous SIOP in premenopausal women with ACS.

Funding: JSPS KAKENHI, Secom Science and Technology Foundation, Takeda Science Foundation, Japan Foundation for Applied Enzymology, AMED-CREST, JSTA-STEP, JST-Moonshot, and Ono Medical Research Foundation.

Citing Articles

Multiomics analysis unveils the cellular ecosystem with clinical relevance in aldosterone-producing adenomas with mutations.

Yokomoto-Umakoshi M, Fujita M, Umakoshi H, Ogasawara T, Iwahashi N, Nakatani K Proc Natl Acad Sci U S A. 2025; 122(9):e2421489122.

PMID: 40009643 PMC: 11892633. DOI: 10.1073/pnas.2421489122.


Plasma Steroid Profiling Between Patients With and Without Diabetes Mellitus in Nonfunctioning Adrenal Incidentalomas.

Nakano Y, Yokomoto-Umakoshi M, Nakatani K, Umakoshi H, Nakao H, Fujita M J Endocr Soc. 2024; 8(9):bvae140.

PMID: 39145114 PMC: 11322837. DOI: 10.1210/jendso/bvae140.

References
1.
Tauchmanova L, Pivonello R, De Martino M, Rusciano A, de Leo M, Ruosi C . Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism. Eur J Endocrinol. 2007; 157(3):359-66. DOI: 10.1530/EJE-07-0137. View

2.
Berke K, Constantinescu G, Masjkur J, Kimpel O, Dischinger U, Peitzsch M . Plasma Steroid Profiling in Patients With Adrenal Incidentaloma. J Clin Endocrinol Metab. 2021; 107(3):e1181-e1192. DOI: 10.1210/clinem/dgab751. View

3.
Ackermann D, Groessl M, Pruijm M, Ponte B, Escher G, dUscio C . Reference intervals for the urinary steroid metabolome: The impact of sex, age, day and night time on human adult steroidogenesis. PLoS One. 2019; 14(3):e0214549. PMC: 6440635. DOI: 10.1371/journal.pone.0214549. View

4.
Johnell O, Kanis J . Epidemiology of osteoporotic fractures. Osteoporos Int. 2004; 16 Suppl 2:S3-7. DOI: 10.1007/s00198-004-1702-6. View

5.
Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A . Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016; 175(2):G1-G34. DOI: 10.1530/EJE-16-0467. View